Clinical Trial Update: Cell Cycle Arrest Proteins for Early Diagnosis of Acute Kidney Injury After Solid Organ Transplant

View source ↗

Summary

Clinical trial evaluating cell cycle arrest proteins as an early diagnostic biomarker for acute kidney injury after solid organ transplant has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Snippet

Sponsor: Policlinico Hospital | Conditions: Acute Kidney Injury | Status: COMPLETED